CARBIOS extends its visibility to American investors at the French Life Science Days conference in New York on June 17th and 18th

CARBIOS (NYSE Alternext in Paris: ALCRB), an innovative green chemistry company specializing in breakthrough technologies dedicated to the recovery of plastic waste and the production of bio-polymers, today announced its participation in the second French Life Science Days conference which will take place in New York City on June 17^th and 18^th.

The French Life Science Days conference is an initiative of France Biotech. The conference brings together French companies in the life sciences space that are publicly listed, and the North American investment communities.  Following the success of the conference’s first edition in 2014, France Biotech is facilitating the 2015 edition of the conference to once again offer SMEs (small and medium enterprises) a forum in which to present and promote their activities to specialized investors in the United States.

In addition to CARBIOS, approximately twenty French companies in the biotech, medtech and cleantech spaces will participate in the French Life Science Days conference to meet specialized North American investors, financial analysts, other financial intermediaries and the press. This edition of the conference is expected to be broadly covered by the press in France and the United States.

French Life Science Days conference, June 17^thand 18^th, 2015

W Hotel, 541 Lexington Avenue, New York, NY 10022

About the «French Life Science Days»

This second edition aims at fostering and boosting the connections between French listed companies and investors worldwide in an effort to facilitate exchanges and demonstrate the solidity of our own financial community. This French Life Science Days initiative brings together key Parisian players (brokers, analysts, auditors, lawyers and communication agencies) to form a sponsorship committee that will support life sciences entrepreneurs. During this occasion, the French biotech companies listed on the NYSE Euronext exchange will introduce themselves to international investors.

About France Biotech

France Biotech brings together the main French life science companies and their expert partners. Its mission is to support the development of the French life sciences by advocating for a favorable regulatory and fiscal environment. In 2004, France Biotech successfully lobbied the French government to create a special fiscal status for innovative start-ups and continues to act as an advocate for the French innovative sector. The organization is currently chaired by Pierre-Olivier Goineau, Co-Founder of ERYTECH Pharma. France Biotech has over 150 members and its board of directors is composed of 17 entrepreneurs in the life sciences.

For more information: http://www.france-biotech.org